Analyst Cory Jubinville, PhD of LifeSci Capital maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report), retaining the price ...

Rocket Pharmaceuticals (RCKT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Gil Blum ...

when an interview with Vector Space Systems' then-CEO Jim Cantrell revealed just how cheap small satellites had become.

The Nintendo Switch's library is vast and constantly growing. Here is every major new Switch game releasing in 2024 or beyond ...

RP-L102, which the firm designed to treat a form of disease caused by FANCA mutations, is already under review with the European Medicines Agency.

Agile Space Industries, based in Colorado, will be expanding to Tulsa. “We think about how big the space industry is and how ...

Rocket's lentiviral (LV) vector-based hematology portfolio consists of late-stage programs for Fanconi Anemia (FA), a difficult-to-treat genetic disease that leads to bone marrow failure (BMF) and ...

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today ...

Mirae Asset Global Investments Co. Ltd. raised its position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 21.5% during the third quarter, according to its most recent filing with the ...

Our Brawlhalla tier list can help you pick your next main and keep up with the ever-changing meta in this popular platform ...

The ’90s and 2000s-vintage New York rock band Poem Rocket — self-described “art-noise-indie genre-defiers” recently reunited for their first live show in decades, and now they’re about ...